Oryx International Growth Fund Ld
26 January 2007
For immediate release 26 January 2007
Oryx International Growth Fund Limited
Not for release, publication or distribution, in whole or in part, in or into
any jurisdiction where to do so would constitute a violation of the relevant
laws of such jurisdiction.
Recommended merger of Oryx International Growth Fund Limited ('Oryx' or the
'Company') with American Opportunity Trust PLC ('AOT') by way of scheme of
arrangement
Oryx announces that at its Extraordinary General Meeting held today, Friday 26
January 2007, called to approve the proposed merger with AOT, the resolution was
duly passed. In addition, all the requisite resolutions proposed at the Court
Meeting of AOT Shareholders and the Extraordinary General Meeting of AOT, both
held today, to effect the proposed merger of Oryx and AOT by way of the Scheme
of Arrangement were also duly passed.
Subject, inter alia, to approval of the Scheme at the Court hearing scheduled
for 22 February 2007, it is expected that the Effective Date for the Scheme will
be 23 February 2007 with dealings in the New Oryx Ordinary Shares to be issued
to AOT Shareholders expected to commence on 26 February 2007. The New Oryx
Ordinary Shares will rank pari passu with existing Oryx Ordinary Shares in all
respects. The last day of dealings in AOT Shares is expected to be 22 February
2007.
It is expected that Oryx will announce on the Effective Date the number of New
Oryx Ordinary Shares that the AOT Shareholders will receive for every 1,000 AOT
Shares that are held by AOT Shareholders.
Terms used in this announcement shall have the same meaning as in the documents
sent to shareholders issued by Oryx and AOT on 21 December 2006.
Enquiries:
Arbuthnot Securities Limited 020 7012 2000
Alastair Moreton
Richard Tulloch
Arbuthnot Securities Limited, which is authorised and regulated in the United
Kingdom by the Financial Services Authority, is acting exclusively for Oryx and
no one else in connection with the Merger and will not be responsible to any
other person for providing the protections afforded to clients of Arbuthnot
Securities Limited or for providing advice in relation to the Merger or the
contents of this announcement. Arbuthnot Securities Limited is not making any
representation or warranty, express or implied, as to the contents of this
announcement.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.